161 related articles for article (PubMed ID: 20533039)
1. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.
Denewer A; Hussein O; Farouk O; Elnahas W; Khater A; El-Saed A
World J Surg; 2010 Sep; 34(9):2204-10. PubMed ID: 20533039
[TBL] [Abstract][Full Text] [Related]
2. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran.
Zehtab N; Jafari M; Barooni M; Nakhaee N; Goudarzi R; Larry Zadeh MH
Asian Pac J Cancer Prev; 2016; 17(2):609-14. PubMed ID: 26925651
[TBL] [Abstract][Full Text] [Related]
6. [Accuracy and direct medical cost of different screening modalities for breast cancer among Chinese women].
Kang M; Zhao Y; Huang Y; Li J; Liu L; Li H
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):236-40. PubMed ID: 24785288
[TBL] [Abstract][Full Text] [Related]
7. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
11. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of aggressive breast cancer screening.
Moskowitz M; Fox SH
Radiology; 1979 Jan; 130(1):253-6. PubMed ID: 103136
[TBL] [Abstract][Full Text] [Related]
13. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
15. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH; Shen Y
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
[TBL] [Abstract][Full Text] [Related]
17. Clinical breast examination in a comprehensive breast cancer screening program: contribution and cost.
Feigin KN; Keating DM; Telford PM; Cohen MA
Radiology; 2006 Sep; 240(3):650-5. PubMed ID: 16926322
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
19. [Early results of breast cancer screening research].
Nowicki A; Stogowska I
Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
